₹ 273600 / 2400 Shares Shares
Minimum Investment
₹108-114 per equity share
11 Nov 2025
13 Nov 2025
1200
₹ 273600
₹108-114
18 Nov 2025
61,78,800 shares(aggregating up to ₹70.44 crore)
₹10 Per Equity Share
2400 Shares
2400 Shares
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity. The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs. The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
2002
Mr. Krishnamurthy Ganesan
Mahamaya Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹108-114 | ₹2,73,600 |
| Individual(max) | ₹108-114 | ₹2,73,600 |
| SHNI(min) | ₹108-114 | ₹4,10,400 |
| SHNI(max) | ₹108-114 | ₹9,57,600 |
| BHNI(min) | ₹108-114 | ₹10,94,400 |
Apply for all eligible candidates, Mahamaya Lifesciences Limited IPO
Mutual funds carry market risk, but diversification and professional management help reduce volatility and improve long-term growth potential.
Yes, NRIs can nominate any Indian resident for their mutual fund holdings and other financial assets via KSquare.
KSquare features only SEBI-registered, vetted NFOs and provides research insights to help investors make informed choices.
Yes, KSquare helps NRIs complete the KYC process digitally, making onboarding quick and hassle-free.
Yes, you can easily switch between funds on the KSquare platform based on your strategy or market movements.
Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.
A Loan Against Mutual Fund allows you to borrow money by pledging your mutual fund units as collateral without selling your investments.
NPS is regulated by PFRDA and offers transparency, safety, and steady growth through professional fund managers.